@bethcd.bsky.social
Postdoc in infectious disease epidemiology and modelling at University of Cambridge. Interested in arboviruses, vaccines, and immunity. Previously at Imperial College London.
Curious about our work?
You can read more about our experiences setting up the group: blogs.imperial.ac.uk/imperial-med... blogs.imperial.ac.uk/imperial-med...
You can read more about our experiences setting up the group: blogs.imperial.ac.uk/imperial-med... blogs.imperial.ac.uk/imperial-med...
Forming the LGBTQIA+ International Support Group - Imperial Medicine Blog
LGBTQIA+ travellers can face unique challenges when travelling abroad. That’s why, researchers from the School of Public Health set up the LGBTQIA+ International Support Group.
blogs.imperial.ac.uk
July 5, 2025 at 10:44 AM
Curious about our work?
You can read more about our experiences setting up the group: blogs.imperial.ac.uk/imperial-med... blogs.imperial.ac.uk/imperial-med...
You can read more about our experiences setting up the group: blogs.imperial.ac.uk/imperial-med... blogs.imperial.ac.uk/imperial-med...
Curious about our work?
We shared our experiences in these blog posts: blogs.imperial.ac.uk/imperial-med... blogs.imperial.ac.uk/imperial-med...
We shared our experiences in these blog posts: blogs.imperial.ac.uk/imperial-med... blogs.imperial.ac.uk/imperial-med...
Forming the LGBTQIA+ International Support Group - Imperial Medicine Blog
LGBTQIA+ travellers can face unique challenges when travelling abroad. That’s why, researchers from the School of Public Health set up the LGBTQIA+ International Support Group.
blogs.imperial.ac.uk
July 5, 2025 at 10:41 AM
Curious about our work?
We shared our experiences in these blog posts: blogs.imperial.ac.uk/imperial-med... blogs.imperial.ac.uk/imperial-med...
We shared our experiences in these blog posts: blogs.imperial.ac.uk/imperial-med... blogs.imperial.ac.uk/imperial-med...
Our work helped inform WHO policy on dengue vaccines—supporting the strategic use of Qdenga where it can do the most good. Huge thanks to my PhD supervisors Ilaria Dorigatti & Neil Ferguson for the opportunity and their support on this project!
June 25, 2025 at 10:38 AM
Our work helped inform WHO policy on dengue vaccines—supporting the strategic use of Qdenga where it can do the most good. Huge thanks to my PhD supervisors Ilaria Dorigatti & Neil Ferguson for the opportunity and their support on this project!
Key findings:
1. Protection varies by serostatus & serotype
2. Cannot rule out an enhanced disease risk for seronegatives infected with serotypes 3 and 4, esp in children <6 years
3. Targeted Qdenga rollout (>6 yrs in high transmission settings) could still reduce hospitalisation burden by up to 20%
1. Protection varies by serostatus & serotype
2. Cannot rule out an enhanced disease risk for seronegatives infected with serotypes 3 and 4, esp in children <6 years
3. Targeted Qdenga rollout (>6 yrs in high transmission settings) could still reduce hospitalisation burden by up to 20%
June 25, 2025 at 10:38 AM
Key findings:
1. Protection varies by serostatus & serotype
2. Cannot rule out an enhanced disease risk for seronegatives infected with serotypes 3 and 4, esp in children <6 years
3. Targeted Qdenga rollout (>6 yrs in high transmission settings) could still reduce hospitalisation burden by up to 20%
1. Protection varies by serostatus & serotype
2. Cannot rule out an enhanced disease risk for seronegatives infected with serotypes 3 and 4, esp in children <6 years
3. Targeted Qdenga rollout (>6 yrs in high transmission settings) could still reduce hospitalisation burden by up to 20%
We built a Bayesian model linking antibody titres to protection-by—serotype, age & serostatus—and embedded it in a transmission model to evaluate real-world impact across settings.
June 25, 2025 at 10:38 AM
We built a Bayesian model linking antibody titres to protection-by—serotype, age & serostatus—and embedded it in a transmission model to evaluate real-world impact across settings.